Product Program year 2025 Source: CMS Open Payments

Apheresis MacHine

Device Nephrology

PDI 04987671040374

Open in the dashboard

General payments

$331,194

78 payments

Research payments

$187,852

9 payments

Through program year 2025, $331,194 in general payments and $187,852 in research payments were reported against Apheresis MacHine (Nephrology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $331,194 78
2025 Research $187,852 9

Breakdown

Who paid General payments · program year 2025
  1. Kaneka Pharma America LLC $331,194 78 payments
Top recipients General payments · program year 2025
  1. Patrick Moriarty Clinical Pharmacology · Kansas City, KS $73,019 22% · 1 payment
  2. Patrick Offi Physician Assistant, Medical · Pittsburgh, PA $60,875 18% · 1 payment
  3. Jeffrey Miller Vascular & Interventional Radiology · Stuart, FL $34,509 10% · 1 payment
  4. J Mocco Neurological Surgery · New York, NY $28,890 9% · 1 payment
  5. Neil Patel Vascular & Interventional Radiology · Burlington, MA $19,251 6% · 1 payment

The top 5 of 72 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Clinical Pharmacology $73,019 23% · 1 practitioner
  2. Physician Assistant, Medical Physician Assistant $60,875 20% · 1 practitioner
  3. Vascular & Interventional Radiology Radiology $53,760 17% · 2 practitioners
  4. Neurological Surgery $51,612 17% · 11 practitioners
  5. Cardiovascular Disease Internal Medicine $29,603 9% · 12 practitioners

The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Kansas $73,019 22% · 1 recipient
  2. Pennsylvania $60,932 18% · 5 recipients
  3. Massachusetts $50,484 15% · 5 recipients
  4. Florida $34,780 11% · 4 recipients
  5. New York $32,509 10% · 4 recipients

The top 5 of 22 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

78 general · 9 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record